Sandoz halts distribution of generic Zantac after carcinogen concerns
by from on (#4QNES)
The pharmaceutical giant's move is the latest action aimed at getting drugs with potentially deadly contaminants off the market.The pharmaceutical giant's move is the latest action aimed at getting drugs with potentially deadly contaminants off the market.